Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Barchart Premier: The most comprehensive method for keeping track of all your investments. FREE 30 Day Trial

Faster, Cleaner, Better.

Akari Therapeutics ADR (AKTX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2015	12-2014	12-2013	12-2012	12-2006
Assets
Current Assets
Cash & Cash Equivalents	68,920	3,328	7,657	1,100	N/A
Receivables	10	N/A	175	10	N/A
Other current assets	728	8	0	0	0
TOTAL	$69,659	$3,335	$7,832	$1,110	$N/A

Non-Current Assets
PPE Net	41	N/A	N/A	2	N/A
Other Non-Current Assets	195	59	0	0	0
TOTAL	$235	$59	$N/A	$2	$N/A

Total Assets	$69,894	$3,395	$7,832	$1,120	$N/A

Liabilities
Current Liabilities
Short Term Debt	N/A	534	N/A	0	N/A
Accounts payable and accrued liabilities	4,321	595	1,231	2,950	0
Accrued Expenses	408	43	N/A	0	N/A
Other current liabilities	16,396	N/A	N/A	0	N/A
TOTAL	$21,125	$1,171	$1,231	$3,850	$N/A

Non-Current Liabilities
Other Non-Current Liabilities	49	0	787	630	0
TOTAL	$49	$N/A	$787	$630	$N/A

Total Liabilities	$21,174	$1,171	$2,018	$4,480	$N/A

Shareholders' Equity
Common Shares	18,341	11,211	675	240	N/A
Retained earnings	-56,797	-11,479	-20,542	-16,920	N/A
Other shareholders' equity	156	46	0	130	0
TOTAL	$48,720	$2,223	$5,814	$-3,360	$N/A

Total Liabilities And Equity	$69,894	$3,395	$7,832	$1,120	$0